Characteristics of the Early Immune Response Following Transplantation of Mouse ES Cell Derived Insulin-producing Cell Clusters

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Jun 10

PMID 20532031

Citations 12

Authors

Ashleigh S Boyd

Kathryn J Wood

Affiliations

Soon will be listed here.

Abstract

Background: The fully differentiated progeny of ES cells (ESC) may eventually be used for cell replacement therapy (CRT). However, elements of the innate immune system may contribute to damage or destruction of these tissues when transplanted.

Methodology/principal Findings: Herein, we assessed the hitherto ill-defined contribution of the early innate immune response in CRT after transplantation of either ESC derived insulin producing cell clusters (IPCCs) or adult pancreatic islets. Ingress of neutrophil or macrophage cells was noted immediately at the site of IPCC transplantation, but this infiltration was attenuated by day three. Gene profiling identified specific inflammatory cytokines and chemokines that were either absent or sharply reduced by three days after IPCC transplantation. Thus, IPCC transplantation provoked less of an early immune response than pancreatic islet transplantation.

Conclusions/significance: Our study offers insights into the characteristics of the immune response of an ESC derived tissue in the incipient stages following transplantation and suggests potential strategies to inhibit cell damage to ensure their long-term perpetuation and functionality in CRT.

Citing Articles

Inflammatory Immune Responses Trigger Rejection of Allogeneic Fibroblasts Transplanted into Mouse Skin.

Farrokhi A, Rahavi M, Jo S, Jalili R, James Lim C, Ghahsary A Cell Transplant. 2022; 31:9636897221113803.

PMID: 35912954 PMC: 9340901. DOI: 10.1177/09636897221113803.

Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus.

Dai P, Qi G, Xu H, Zhu M, Li J, Chen Y Stem Cell Res Ther. 2022; 13(1):370.

PMID: 35902971 PMC: 9331803. DOI: 10.1186/s13287-022-03020-w.

Single cell analysis of human foetal liver captures the transcriptional profile of hepatobiliary hybrid progenitors.

Segal J, Kent D, Wesche D, Ng S, Serra M, Oules B Nat Commun. 2019; 10(1):3350.

PMID: 31350390 PMC: 6659636. DOI: 10.1038/s41467-019-11266-x.

Cell Therapy for Type 1 Diabetes: Current and Future Strategies.

Aghazadeh Y, Nostro M Curr Diab Rep. 2017; 17(6):37.

PMID: 28432571 DOI: 10.1007/s11892-017-0863-6.

Immunological Properties of Corneal Epithelial-Like Cells Derived from Human Embryonic Stem Cells.

Wang Z, Zhou Q, Duan H, Wang Y, Dong M, Shi W PLoS One. 2016; 11(3):e0150731.

PMID: 26977925 PMC: 4792422. DOI: 10.1371/journal.pone.0150731.

References

Wu D, Boyd A, Wood K . Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells. 2008; 26(8):1939-50. DOI: 10.1634/stemcells.2008-0078. View

El-Sawy T, Belperio J, Strieter R, Remick D, Fairchild R . Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation. 2005; 112(3):320-31. DOI: 10.1161/CIRCULATIONAHA.104.516708. View

Robertson N, Brook F, Gardner R, Cobbold S, Waldmann H, Fairchild P . Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci U S A. 2007; 104(52):20920-5. PMC: 2409242. DOI: 10.1073/pnas.0710265105. View

Turvey S, Gonzalez-Nicolini V, Kingsley C, Larregina A, Morris P, Castro M . Fas ligand-transfected myoblasts and islet cell transplantation. Transplantation. 2000; 69(9):1972-6. DOI: 10.1097/00007890-200005150-00043. View

Bertuzzi F, Marzorati S, Maffi P, Piemonti L, Melzi R, De Taddeo F . Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type 1 diabetic recipients. J Clin Endocrinol Metab. 2004; 89(11):5724-8. DOI: 10.1210/jc.2004-0659. View

Bonde S, Zavazava N . Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells. 2006; 24(10):2192-201. DOI: 10.1634/stemcells.2006-0022. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Adams D, Hubscher S, Fear J, Johnston J, Shaw S, Afford S . Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation. Transplantation. 1996; 61(5):817-25. DOI: 10.1097/00007890-199603150-00024. View

Game D, Lechler R . Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol. 2002; 10(2-3):101-8. DOI: 10.1016/s0966-3274(02)00055-2. View

10.

Kondo T, Morita K, Watarai Y, AUERBACH M, Taub D, Novick A . Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation. 2001; 69(5):969-77. DOI: 10.1097/00007890-200003150-00051. View

11.

Olszewski W . Innate immunity processes in organ allografting--their contribution to acute and chronic rejection. Ann Transplant. 2005; 10(2):5-9. View

12.

Rus H, Cudrici C, Niculescu F . The role of the complement system in innate immunity. Immunol Res. 2005; 33(2):103-12. DOI: 10.1385/IR:33:2:103. View

13.

Blyszczuk P, Asbrand C, Rozzo A, Kania G, St-Onge L, Rupnik M . Embryonic stem cells differentiate into insulin-producing cells without selection of nestin-expressing cells. Int J Dev Biol. 2004; 48(10):1095-104. DOI: 10.1387/ijdb.041904pb. View

14.

Koch C, Khalpey Z, Platt J . Accommodation: preventing injury in transplantation and disease. J Immunol. 2004; 172(9):5143-8. DOI: 10.4049/jimmunol.172.9.5143. View

15.

Jones N, Carvalho-Gaspar M, Luo S, Brook M, Martin L, Wood K . Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help. J Immunol. 2006; 176(4):2316-23. DOI: 10.4049/jimmunol.176.4.2316. View

16.

Medzhitov R, Janeway Jr C . Innate immunity: impact on the adaptive immune response. Curr Opin Immunol. 1997; 9(1):4-9. DOI: 10.1016/s0952-7915(97)80152-5. View

17.

El-Sawy T, Miura M, Fairchild R . Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol. 2004; 165(1):147-57. PMC: 1618530. DOI: 10.1016/s0002-9440(10)63283-x. View

18.

Magliocca J, Held I, Odorico J . Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev. 2006; 15(5):707-17. DOI: 10.1089/scd.2006.15.707. View

19.

Quigg R . Complement and the kidney. J Immunol. 2003; 171(7):3319-24. DOI: 10.4049/jimmunol.171.7.3319. View

20.

Burns W, Wang Y, Tang P, Ranjbaran H, Iakimov A, Kim J . Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries. Am J Transplant. 2005; 5(6):1226-36. DOI: 10.1111/j.1600-6143.2005.00892.x. View